3/4/2026, 7:55:03 AM
SINGAPORE — March 4, 2026 — Leads & Copy — EUDA Health Holdings Limited (NASDAQ: EUDA) announced it has fully repurchased and cancelled the warrant previously issued to Streeterville Capital, LLC.
The warrant, immediately exercisable into up to 2,000,000 newly issued ordinary shares, was initially part of a securities purchase agreement dated November 26, 2025, with an accredited investor. It was later amended on December 16, 2025, and January 13, 2026.
On February 27, 2026, EUDA Health Holdings completed the repurchase of the warrant for US$125,000. The warrant has been cancelled and is no longer outstanding. The company said that there are no warrants remaining under this agreement, and the potential issuance of shares associated with the warrant has been fully eliminated.
EUDA Health Holdings Limited is a non-invasive healthcare provider in Asia, focusing on Singapore, Malaysia, and China. It aims to be a market leader in non-invasive and preventive healthcare, with a strategic focus on the longevity sector. The company intends to address the healthcare needs of over 1.8 billion people, offering accessible, science-backed health solutions to transform regional healthcare.
EUDA also runs a Singapore-based property management business.
Source: EUDA Health Holdings Limited
